INR 348.75
(0.2%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 147.55 Billion INR | 32.05% |
2022 | 111.74 Billion INR | 39.25% |
2021 | 80.24 Billion INR | 15.13% |
2020 | 69.7 Billion INR | 12.21% |
2019 | 62.11 Billion INR | 15.43% |
2018 | 53.81 Billion INR | 35.27% |
2017 | 39.78 Billion INR | 3.44% |
2016 | 38.45 Billion INR | 12.95% |
2015 | 34.05 Billion INR | 11.3% |
2014 | 30.59 Billion INR | 7.29% |
2013 | 28.51 Billion INR | 17.52% |
2012 | 24.26 Billion INR | 18.41% |
2011 | 20.49 Billion INR | -10.93% |
2010 | 23 Billion INR | 12.97% |
2009 | 20.36 Billion INR | 48.44% |
2008 | 13.71 Billion INR | 64.61% |
2007 | 8.33 Billion INR | 1.29% |
2006 | 8.22 Billion INR | 19.67% |
2005 | 6.87 Billion INR | 6.36% |
2004 | 6.46 Billion INR | 28.79% |
2003 | 5.01 Billion INR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 34.32 Billion INR | -12.36% |
2024 Q2 | 35.45 Billion INR | 3.27% |
2023 Q4 | 39.17 Billion INR | 10.38% |
2023 FY | 147.55 Billion INR | 32.05% |
2023 Q1 | 34.22 Billion INR | -9.31% |
2023 Q2 | 34.62 Billion INR | 1.16% |
2023 Q3 | 35.48 Billion INR | 2.5% |
2022 Q3 | 29.41 Billion INR | 26.79% |
2022 Q4 | 37.73 Billion INR | 28.32% |
2022 Q1 | 21.39 Billion INR | -4.89% |
2022 Q2 | 23.19 Billion INR | 8.42% |
2022 FY | 111.74 Billion INR | 39.25% |
2021 Q4 | 22.49 Billion INR | 3.47% |
2021 FY | 80.24 Billion INR | 15.13% |
2021 Q1 | 17.6 Billion INR | 3.38% |
2021 Q2 | 18.4 Billion INR | 4.53% |
2021 Q3 | 21.74 Billion INR | 18.14% |
2020 Q1 | 16.71 Billion INR | 17.26% |
2020 Q4 | 17.03 Billion INR | -8.0% |
2020 Q3 | 18.51 Billion INR | 6.09% |
2020 Q2 | 17.44 Billion INR | 4.4% |
2020 FY | 69.7 Billion INR | 12.21% |
2019 Q3 | 17.48 Billion INR | 11.19% |
2019 Q2 | 15.72 Billion INR | 7.25% |
2019 FY | 62.11 Billion INR | 15.43% |
2019 Q1 | 14.65 Billion INR | 5.04% |
2019 Q4 | 14.25 Billion INR | -18.47% |
2018 FY | 53.81 Billion INR | 35.27% |
2018 Q4 | 13.95 Billion INR | -9.43% |
2018 Q3 | 15.4 Billion INR | 16.64% |
2018 Q2 | 13.21 Billion INR | 17.55% |
2018 Q1 | 11.23 Billion INR | -3.91% |
2017 Q2 | 9.68 Billion INR | 4.44% |
2017 Q1 | 9.27 Billion INR | 0.23% |
2017 Q3 | 10.57 Billion INR | 9.22% |
2017 FY | 39.78 Billion INR | 3.44% |
2017 Q4 | 11.69 Billion INR | 10.55% |
2016 Q2 | 9.32 Billion INR | -4.1% |
2016 FY | 38.45 Billion INR | 12.95% |
2016 Q1 | 9.72 Billion INR | 0.27% |
2016 Q3 | 10.22 Billion INR | 9.7% |
2016 Q4 | 9.25 Billion INR | -9.51% |
2015 Q4 | 9.69 Billion INR | 17.05% |
2015 FY | 34.05 Billion INR | 11.3% |
2015 Q2 | 8.28 Billion INR | 6.36% |
2015 Q3 | 8.28 Billion INR | -0.03% |
2015 Q1 | 7.78 Billion INR | -6.11% |
2014 FY | 30.59 Billion INR | 7.29% |
2014 Q3 | 7.61 Billion INR | 1.52% |
2014 Q4 | 8.29 Billion INR | 9.0% |
2014 Q2 | 7.49 Billion INR | 4.3% |
2014 Q1 | 7.18 Billion INR | -0.33% |
2013 Q3 | 7.01 Billion INR | -4.5% |
2013 FY | 28.51 Billion INR | 17.52% |
2013 Q1 | 6.94 Billion INR | 10.49% |
2013 Q2 | 7.34 Billion INR | 5.68% |
2013 Q4 | 7.21 Billion INR | 2.85% |
2012 Q2 | 5.92 Billion INR | 3.77% |
2012 FY | 24.26 Billion INR | 18.41% |
2012 Q4 | 6.28 Billion INR | -0.85% |
2012 Q3 | 6.34 Billion INR | 7.06% |
2012 Q1 | 5.7 Billion INR | -3.03% |
2011 Q4 | 5.88 Billion INR | 13.95% |
2011 Q3 | 5.16 Billion INR | 0.0% |
2011 FY | 20.49 Billion INR | -10.93% |
2010 FY | 23 Billion INR | 12.97% |
2009 FY | 20.36 Billion INR | 48.44% |
2008 FY | 13.71 Billion INR | 64.61% |
2007 FY | 8.33 Billion INR | 1.29% |
2006 FY | 8.22 Billion INR | 19.67% |
2005 FY | 6.87 Billion INR | 6.36% |
2004 FY | 6.46 Billion INR | 28.79% |
2003 FY | 5.01 Billion INR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Blue Jet Healthcare Limited | 7.11 Billion INR | -1973.601% |
Concord Biotech Limited | 9.98 Billion INR | -1378.442% |
Dishman Carbogen Amcis Limited | 26.15 Billion INR | -464.105% |
Jubilant Ingrevia Limited | 41 Billion INR | -259.856% |
Lyka Labs Limited | 1.05 Billion INR | -13935.363% |
Panacea Biotec Limited | 5.59 Billion INR | -2538.858% |
Piramal Pharma Limited | 81.71 Billion INR | -80.583% |
SMS Lifesciences India Limited | 3.05 Billion INR | -4722.78% |
Supriya Lifescience Limited | 5.7 Billion INR | -2487.04% |
Syngene International Limited | 34.88 Billion INR | -322.969% |
TAKE Solutions Limited | 656.08 Million INR | -22390.702% |
Zota Health Care Limited | 1.8 Billion INR | -8075.424% |